COMPASS THERAPEUTICS, INC. Accrued Liabilities, Current
COMPASS THERAPEUTICS, INC. (CMPX) had Accrued Liabilities, Current of $11.59 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Liabilities, Current $11.59M.
- 2026-03-31: Accrued Liabilities, Current $8.00M.
- 2025-12-31: Accrued Liabilities, Current $11.38M.
- 2025-09-30: Accrued Liabilities, Current $8.68M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $11.59M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $8.00M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $11.38M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $8.68M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $10.99M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $13.21M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $6.29M 10-K · filed 2026-03-05 |
| 2024-09-30 | $2.92M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $7.23M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.81M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $2.51M 10-K · filed 2025-02-27 |
| 2023-09-30 | $5.64M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $7.83M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $8.94M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $11.69M 10-K · filed 2024-03-21 |
| 2022-09-30 | $5.74M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $3.30M 10-Q · filed 2022-08-01 |
| 2022-03-31 | $8.05M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $8.78M 10-K · filed 2023-03-15 |
| 2021-09-30 | $2.00M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.17M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $1.29M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $1.57M 10-K · filed 2022-03-18 |
| 2020-09-30 | $1.36M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $2.57M 10-Q · filed 2020-08-13 |
| 2019-12-31 | $3.12M 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |